Originally published July 12 2005
Pharmaceutical company making deals in wake of promising AIDS vaccine
by Mike Adams, the Health Ranger, NaturalNews Editor
According to webpronews.com, GlaxoSmithKline has signed a commitment to distribute the latest AIDS vaccine if it passes all trials, based solely on the HIV-based medicine's success in animal tests.
For twenty years, the human immunodeficiency virus (HIV) has been thwarting the attempts of scientists to develop an effective vaccine.
Scientists are seeing major promise in the latest batch, so much promise that major pharmaceutical company GlaxoSmithKline is making deals.
"For now, we think it's the best thing we've seen yet, ever...
and that it really deserves full scale testing, and we hope that the data will be good," says Dr. Julie McElrath, who has been researching the hopeful cure.
Testing has just begun around the world on the vaccine that uses a synthetic form of HIV to provoke the body to produce an immune response.
It's not going to give you HIV infection, but it's going to allow the body to recognize pieces of HIV and to make an immune response," Dr. McElrath said.
There have been 50 vaccines developed and tested since then, but all have failed to contain the virus that proves to be a tricky and resilient one.
It is so promising that pharmaceutical giant GlaxoSmithKline has joined the effort with the International AIDS Vaccine Initiative (IAVI) by signing a commitment for development and distribution should the vaccine pass all trials.
Private companies rarely join non-profit efforts unless they think a new drug has potential.
Glaxo has promised to produce the new vaccine at affordable prices to developing countries which account for 95% of all new HIV infections.
Though only 0.7% of the world's population is living with AIDS, 60% of the infected live in sub-Saharan Africa, according to the United Nations.
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml